GNFT - Hot Stocks: Spider-Man carries AMC; SBUX downgrade; NVAX approval; SCS earnings; GNFT licensing deal

Meme-stock favorite AMC (NYSE:AMC) returned to the headlines during Friday's midday trading, posting a double-digit percentage gain on strong early box office totals for the new Spider-Man movie. Elsewhere in the market, drug development news prompted notable gains in Novavax (NASDAQ:NVAX) and Genfit (NASDAQ:GNFT). NVAX climbed on a regulatory approval for its COVID vaccine, while a licensing deal sparked a massive buying spree in shares of GNFT. Turning to some of the day's notable decliners, an analyst's downgrade put pressure on Starbucks (NASDAQ:SBUX). At the same time, Steelcase (NYSE:SCS) slipped on earnings news. Gainers  AMC (AMC) soared nearly 19% in midday trading amid hope that the strong performance for the latest Spider-Man movie points to a long-term recovery in the movie theater industry. The theater chain reported that Spider-Man: No Way Home delivered its best-ever December opening. Novavax (NVAX) also showed midday strength, climbing almost 12% on a key regulatory

For further details see:

Hot Stocks: Spider-Man carries AMC; SBUX downgrade; NVAX approval; SCS earnings; GNFT licensing deal